JP2008523134A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008523134A5 JP2008523134A5 JP2007546165A JP2007546165A JP2008523134A5 JP 2008523134 A5 JP2008523134 A5 JP 2008523134A5 JP 2007546165 A JP2007546165 A JP 2007546165A JP 2007546165 A JP2007546165 A JP 2007546165A JP 2008523134 A5 JP2008523134 A5 JP 2008523134A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- pyrazolo
- oxy
- amino
- phenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- -1 pyrazolopyrimidine compound Chemical class 0.000 claims description 235
- 125000000217 alkyl group Chemical group 0.000 claims description 202
- 229910052757 nitrogen Inorganic materials 0.000 claims description 66
- 229910052739 hydrogen Inorganic materials 0.000 claims description 55
- 239000001257 hydrogen Substances 0.000 claims description 55
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 45
- 125000001424 substituent group Chemical group 0.000 claims description 35
- 125000000623 heterocyclic group Chemical group 0.000 claims description 34
- 229910052760 oxygen Inorganic materials 0.000 claims description 32
- 125000005843 halogen group Chemical group 0.000 claims description 31
- 125000003545 alkoxy group Chemical group 0.000 claims description 29
- 125000001589 carboacyl group Chemical group 0.000 claims description 26
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 26
- 125000001072 heteroaryl group Chemical group 0.000 claims description 25
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 25
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 24
- 125000003282 alkyl amino group Chemical group 0.000 claims description 20
- 125000003118 aryl group Chemical group 0.000 claims description 20
- 229910052717 sulfur Chemical group 0.000 claims description 20
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 claims description 18
- 125000005236 alkanoylamino group Chemical group 0.000 claims description 17
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 15
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims description 15
- 125000003342 alkenyl group Chemical group 0.000 claims description 14
- 125000003302 alkenyloxy group Chemical group 0.000 claims description 14
- 125000000304 alkynyl group Chemical group 0.000 claims description 14
- 125000005133 alkynyloxy group Chemical group 0.000 claims description 14
- 125000004397 aminosulfonyl group Chemical group NS(=O)(=O)* 0.000 claims description 14
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 14
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 13
- 239000001301 oxygen Chemical group 0.000 claims description 13
- 125000004076 pyridyl group Chemical group 0.000 claims description 13
- 125000004390 alkyl sulfonyl group Chemical group 0.000 claims description 12
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims description 11
- 125000004644 alkyl sulfinyl group Chemical group 0.000 claims description 11
- 125000004414 alkyl thio group Chemical group 0.000 claims description 11
- 125000005842 heteroatom Chemical group 0.000 claims description 11
- 125000004105 2-pyridyl group Chemical group N1=C([*])C([H])=C([H])C([H])=C1[H] 0.000 claims description 10
- 150000002431 hydrogen Chemical class 0.000 claims description 10
- 125000004423 acyloxy group Chemical group 0.000 claims description 9
- 125000005115 alkyl carbamoyl group Chemical group 0.000 claims description 9
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims description 8
- 125000001153 fluoro group Chemical group F* 0.000 claims description 8
- 239000011593 sulfur Chemical group 0.000 claims description 8
- 125000005153 alkyl sulfamoyl group Chemical group 0.000 claims description 7
- 125000002883 imidazolyl group Chemical group 0.000 claims description 6
- 125000000842 isoxazolyl group Chemical group 0.000 claims description 6
- 125000003373 pyrazinyl group Chemical group 0.000 claims description 6
- 125000002098 pyridazinyl group Chemical group 0.000 claims description 6
- 125000000714 pyrimidinyl group Chemical group 0.000 claims description 6
- 125000000022 2-aminoethyl group Chemical group [H]C([*])([H])C([H])([H])N([H])[H] 0.000 claims description 5
- 125000001340 2-chloroethyl group Chemical group [H]C([H])(Cl)C([H])([H])* 0.000 claims description 5
- 125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 claims description 5
- 125000005278 alkyl sulfonyloxy group Chemical group 0.000 claims description 5
- 229910002091 carbon monoxide Inorganic materials 0.000 claims description 5
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 claims description 5
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims description 5
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims description 5
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 5
- 125000004433 nitrogen atom Chemical group N* 0.000 claims description 5
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 claims description 5
- 125000003396 thiol group Chemical class [H]S* 0.000 claims description 5
- 125000004180 3-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(F)=C1[H] 0.000 claims description 4
- 229910052799 carbon Inorganic materials 0.000 claims description 4
- 125000004200 2-methoxyethyl group Chemical group [H]C([H])([H])OC([H])([H])C([H])([H])* 0.000 claims description 3
- QOXOZONBQWIKDA-UHFFFAOYSA-N 3-hydroxypropyl Chemical group [CH2]CCO QOXOZONBQWIKDA-UHFFFAOYSA-N 0.000 claims description 3
- 125000001731 2-cyanoethyl group Chemical group [H]C([H])(*)C([H])([H])C#N 0.000 claims description 2
- 125000004777 2-fluoroethyl group Chemical group [H]C([H])(F)C([H])([H])* 0.000 claims description 2
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 claims description 2
- 125000001494 2-propynyl group Chemical group [H]C#CC([H])([H])* 0.000 claims description 2
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 claims description 2
- 150000001335 aliphatic alkanes Chemical class 0.000 claims description 2
- HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 claims description 2
- 125000004202 aminomethyl group Chemical group [H]N([H])C([H])([H])* 0.000 claims description 2
- 125000004429 atom Chemical group 0.000 claims description 2
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 claims description 2
- 125000004218 chloromethyl group Chemical group [H]C([H])(Cl)* 0.000 claims description 2
- 125000003754 ethoxycarbonyl group Chemical group C(=O)(OCC)* 0.000 claims description 2
- 125000006534 ethyl amino methyl group Chemical group [H]N(C([H])([H])*)C([H])([H])C([H])([H])[H] 0.000 claims description 2
- 125000002534 ethynyl group Chemical group [H]C#C* 0.000 claims description 2
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 claims description 2
- 125000004184 methoxymethyl group Chemical group [H]C([H])([H])OC([H])([H])* 0.000 claims description 2
- 125000006533 methyl amino methyl group Chemical group [H]N(C([H])([H])[H])C([H])([H])* 0.000 claims description 2
- 125000004170 methylsulfonyl group Chemical group [H]C([H])([H])S(*)(=O)=O 0.000 claims description 2
- 125000001501 propionyl group Chemical group O=C([*])C([H])([H])C([H])([H])[H] 0.000 claims description 2
- 229920006395 saturated elastomer Polymers 0.000 claims description 2
- 150000003839 salts Chemical class 0.000 claims 36
- OKKJLVBELUTLKV-UHFFFAOYSA-N methanol Natural products OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims 15
- 125000000524 functional group Chemical group 0.000 claims 11
- 150000001875 compounds Chemical class 0.000 claims 9
- 125000000392 cycloalkenyl group Chemical group 0.000 claims 7
- 125000004356 hydroxy functional group Chemical group O* 0.000 claims 7
- 238000004519 manufacturing process Methods 0.000 claims 6
- 238000000034 method Methods 0.000 claims 6
- 125000006239 protecting group Chemical group 0.000 claims 6
- 238000006243 chemical reaction Methods 0.000 claims 5
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 claims 4
- OGEBRHQLRGFBNV-RZDIXWSQSA-N chembl2036808 Chemical compound C12=NC(NCCCC)=NC=C2C(C=2C=CC(F)=CC=2)=NN1C[C@H]1CC[C@H](N)CC1 OGEBRHQLRGFBNV-RZDIXWSQSA-N 0.000 claims 3
- 125000000904 isoindolyl group Chemical group C=1(NC=C2C=CC=CC12)* 0.000 claims 3
- 125000004485 2-pyrrolidinyl group Chemical group [H]N1C([H])([H])C([H])([H])C([H])([H])C1([H])* 0.000 claims 2
- 150000001412 amines Chemical class 0.000 claims 2
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 claims 2
- IZQPBXPMSBFBCG-HXUWFJFHSA-N (2r)-1-[2-[[4-[3-methyl-4-(6-methylpyridin-3-yl)oxyanilino]-1h-pyrazolo[3,4-d]pyrimidin-3-yl]oxy]ethyl]pyrrolidin-2-ol Chemical compound C1=NC(C)=CC=C1OC(C(=C1)C)=CC=C1NC1=NC=NC2=C1C(OCCN1[C@@H](CCC1)O)=NN2 IZQPBXPMSBFBCG-HXUWFJFHSA-N 0.000 claims 1
- IZQPBXPMSBFBCG-FQEVSTJZSA-N (2s)-1-[2-[[4-[3-methyl-4-(6-methylpyridin-3-yl)oxyanilino]-1h-pyrazolo[3,4-d]pyrimidin-3-yl]oxy]ethyl]pyrrolidin-2-ol Chemical compound C1=NC(C)=CC=C1OC(C(=C1)C)=CC=C1NC1=NC=NC2=C1C(OCCN1[C@H](CCC1)O)=NN2 IZQPBXPMSBFBCG-FQEVSTJZSA-N 0.000 claims 1
- UUCPCAZWRGRGCP-QGZVFWFLSA-N (3r)-1-[2-[[4-[3-chloro-4-(pyridin-2-ylmethoxy)anilino]-1h-pyrazolo[3,4-d]pyrimidin-3-yl]oxy]ethyl]pyrrolidin-3-ol Chemical compound C1[C@H](O)CCN1CCOC1=NNC2=NC=NC(NC=3C=C(Cl)C(OCC=4N=CC=CC=4)=CC=3)=C12 UUCPCAZWRGRGCP-QGZVFWFLSA-N 0.000 claims 1
- UUCPCAZWRGRGCP-KRWDZBQOSA-N (3s)-1-[2-[[4-[3-chloro-4-(pyridin-2-ylmethoxy)anilino]-1h-pyrazolo[3,4-d]pyrimidin-3-yl]oxy]ethyl]pyrrolidin-3-ol Chemical compound C1[C@@H](O)CCN1CCOC1=NNC2=NC=NC(NC=3C=C(Cl)C(OCC=4N=CC=CC=4)=CC=3)=C12 UUCPCAZWRGRGCP-KRWDZBQOSA-N 0.000 claims 1
- UWUFUUGZSOQBCY-UHFFFAOYSA-N 1-[2-[[4-[3-chloro-4-(6-methylpyridin-3-yl)oxyanilino]-1h-pyrazolo[3,4-d]pyrimidin-3-yl]oxy]ethyl]piperidin-4-ol Chemical compound C1=NC(C)=CC=C1OC(C(=C1)Cl)=CC=C1NC1=NC=NC2=C1C(OCCN1CCC(O)CC1)=NN2 UWUFUUGZSOQBCY-UHFFFAOYSA-N 0.000 claims 1
- OOWWSELYEWEGFH-UHFFFAOYSA-N 1-[2-[[4-[3-chloro-4-(pyridin-2-ylmethoxy)anilino]-1h-pyrazolo[3,4-d]pyrimidin-3-yl]oxy]ethyl]piperidin-4-ol Chemical compound C1CC(O)CCN1CCOC1=NNC2=NC=NC(NC=3C=C(Cl)C(OCC=4N=CC=CC=4)=CC=3)=C12 OOWWSELYEWEGFH-UHFFFAOYSA-N 0.000 claims 1
- GBRXUAZIMSFHPJ-UHFFFAOYSA-N 1-[2-[[4-[3-chloro-4-(pyridin-2-ylmethoxy)anilino]-1h-pyrazolo[3,4-d]pyrimidin-3-yl]oxy]ethyl]pyrrolidin-2-one Chemical compound C=1C=C(OCC=2N=CC=CC=2)C(Cl)=CC=1NC(C1=2)=NC=NC=2NN=C1OCCN1CCCC1=O GBRXUAZIMSFHPJ-UHFFFAOYSA-N 0.000 claims 1
- ZXQYLBWEILBYIE-UHFFFAOYSA-N 1-[2-[[4-[3-chloro-4-[(3-fluorophenyl)methoxy]anilino]-1h-pyrazolo[3,4-d]pyrimidin-3-yl]oxy]ethyl]piperidin-4-ol Chemical compound C1CC(O)CCN1CCOC1=NNC2=NC=NC(NC=3C=C(Cl)C(OCC=4C=C(F)C=CC=4)=CC=3)=C12 ZXQYLBWEILBYIE-UHFFFAOYSA-N 0.000 claims 1
- JDUVCKXVGSZRRN-UHFFFAOYSA-N 1-[2-[[4-[3-ethyl-4-(pyridin-2-ylmethoxy)anilino]-1h-pyrazolo[3,4-d]pyrimidin-3-yl]oxy]ethyl]piperidin-4-ol Chemical compound C=1C=C(OCC=2N=CC=CC=2)C(CC)=CC=1NC(C1=2)=NC=NC=2NN=C1OCCN1CCC(O)CC1 JDUVCKXVGSZRRN-UHFFFAOYSA-N 0.000 claims 1
- KOBKLBFNTIJTTR-UHFFFAOYSA-N 1-[2-[[4-[3-fluoro-4-(6-methylpyridin-3-yl)oxyanilino]-1h-pyrazolo[3,4-d]pyrimidin-3-yl]oxy]ethyl]piperidin-4-ol Chemical compound C1=NC(C)=CC=C1OC(C(=C1)F)=CC=C1NC1=NC=NC2=C1C(OCCN1CCC(O)CC1)=NN2 KOBKLBFNTIJTTR-UHFFFAOYSA-N 0.000 claims 1
- VMDUWDNQTGHKSN-UHFFFAOYSA-N 1-[2-[[4-[3-methoxy-4-(pyridin-2-ylmethoxy)anilino]-1h-pyrazolo[3,4-d]pyrimidin-3-yl]oxy]ethyl]piperidin-4-ol Chemical compound C=1C=C(OCC=2N=CC=CC=2)C(OC)=CC=1NC(C1=2)=NC=NC=2NN=C1OCCN1CCC(O)CC1 VMDUWDNQTGHKSN-UHFFFAOYSA-N 0.000 claims 1
- LYCPWHYCBIEJPN-UHFFFAOYSA-N 1-[2-[[4-[3-methyl-4-(6-methylpyridin-3-yl)oxyanilino]-1h-pyrazolo[3,4-d]pyrimidin-3-yl]oxy]ethyl]piperidin-4-ol Chemical compound C1=NC(C)=CC=C1OC(C(=C1)C)=CC=C1NC1=NC=NC2=C1C(OCCN1CCC(O)CC1)=NN2 LYCPWHYCBIEJPN-UHFFFAOYSA-N 0.000 claims 1
- GYDNMCFYNSRRTC-UHFFFAOYSA-N 1-[2-[[4-[3-methyl-4-(pyridin-2-ylmethoxy)anilino]-1h-pyrazolo[3,4-d]pyrimidin-3-yl]oxy]ethyl]piperidin-4-ol Chemical compound C=1C=C(OCC=2N=CC=CC=2)C(C)=CC=1NC(C1=2)=NC=NC=2NN=C1OCCN1CCC(O)CC1 GYDNMCFYNSRRTC-UHFFFAOYSA-N 0.000 claims 1
- PXOQNEQRSUORAM-UHFFFAOYSA-N 1-[2-[[4-[4-[(3-fluorophenyl)methoxy]-3-methoxyanilino]-1h-pyrazolo[3,4-d]pyrimidin-3-yl]oxy]ethyl]piperidin-4-ol Chemical compound C=1C=C(OCC=2C=C(F)C=CC=2)C(OC)=CC=1NC(C1=2)=NC=NC=2NN=C1OCCN1CCC(O)CC1 PXOQNEQRSUORAM-UHFFFAOYSA-N 0.000 claims 1
- RVSMZHTVMMGSFY-UHFFFAOYSA-N 1-[2-[[4-[4-[(3-fluorophenyl)methoxy]-3-methylanilino]-1h-pyrazolo[3,4-d]pyrimidin-3-yl]oxy]ethyl]piperidin-4-ol Chemical compound C=1C=C(OCC=2C=C(F)C=CC=2)C(C)=CC=1NC(C1=2)=NC=NC=2NN=C1OCCN1CCC(O)CC1 RVSMZHTVMMGSFY-UHFFFAOYSA-N 0.000 claims 1
- YJELZTGEMAQGHU-UHFFFAOYSA-N 1-[3-[[4-[3-chloro-4-(pyridin-2-ylmethoxy)anilino]-1h-pyrazolo[3,4-d]pyrimidin-3-yl]oxy]propyl]piperidin-4-ol Chemical compound C1CC(O)CCN1CCCOC1=NNC2=NC=NC(NC=3C=C(Cl)C(OCC=4N=CC=CC=4)=CC=3)=C12 YJELZTGEMAQGHU-UHFFFAOYSA-N 0.000 claims 1
- QFKHRAMBZLTSDV-UHFFFAOYSA-N 1-[4-[2-[[4-[3-chloro-4-(6-methylpyridin-3-yl)oxyanilino]-1h-pyrazolo[3,4-d]pyrimidin-3-yl]oxy]ethyl]piperazin-1-yl]ethanone Chemical compound C1CN(C(=O)C)CCN1CCOC1=NNC2=NC=NC(NC=3C=C(Cl)C(OC=4C=NC(C)=CC=4)=CC=3)=C12 QFKHRAMBZLTSDV-UHFFFAOYSA-N 0.000 claims 1
- JNCKWWADGCZZGL-UHFFFAOYSA-N 1-[4-[2-[[4-[3-chloro-4-(pyridin-2-ylmethoxy)anilino]-1h-pyrazolo[3,4-d]pyrimidin-3-yl]oxy]ethyl]piperazin-1-yl]ethanone Chemical compound C1CN(C(=O)C)CCN1CCOC1=NNC2=NC=NC(NC=3C=C(Cl)C(OCC=4N=CC=CC=4)=CC=3)=C12 JNCKWWADGCZZGL-UHFFFAOYSA-N 0.000 claims 1
- HUFIMPWZKFFPQW-UHFFFAOYSA-N 1-[4-[2-[[4-[3-methyl-4-(6-methylpyridin-3-yl)oxyanilino]-1h-pyrazolo[3,4-d]pyrimidin-3-yl]oxy]ethyl]piperazin-1-yl]ethanone Chemical compound C1CN(C(=O)C)CCN1CCOC1=NNC2=NC=NC(NC=3C=C(C)C(OC=4C=NC(C)=CC=4)=CC=3)=C12 HUFIMPWZKFFPQW-UHFFFAOYSA-N 0.000 claims 1
- MCUKWCRQNBUPGQ-UHFFFAOYSA-N 1-[4-[3-[[4-[3-chloro-4-(pyridin-2-ylmethoxy)anilino]-1h-pyrazolo[3,4-d]pyrimidin-3-yl]oxy]propyl]piperazin-1-yl]ethanone Chemical compound C1CN(C(=O)C)CCN1CCCOC1=NNC2=NC=NC(NC=3C=C(Cl)C(OCC=4N=CC=CC=4)=CC=3)=C12 MCUKWCRQNBUPGQ-UHFFFAOYSA-N 0.000 claims 1
- OKMXQCNGZVQOKH-UHFFFAOYSA-N 2-[2-[[4-[3-chloro-4-(6-methylpyridin-3-yl)oxyanilino]-1h-pyrazolo[3,4-d]pyrimidin-3-yl]oxy]ethyl-methylamino]ethanol Chemical compound C=12C(OCCN(CCO)C)=NNC2=NC=NC=1NC(C=C1Cl)=CC=C1OC1=CC=C(C)N=C1 OKMXQCNGZVQOKH-UHFFFAOYSA-N 0.000 claims 1
- GTLHFFSIEBUGAS-UHFFFAOYSA-N 2-[2-[[4-[3-chloro-4-(pyridin-2-ylmethoxy)anilino]-1h-pyrazolo[3,4-d]pyrimidin-3-yl]oxy]ethyl-(2-hydroxyethyl)amino]ethanol Chemical compound C=12C(OCCN(CCO)CCO)=NNC2=NC=NC=1NC(C=C1Cl)=CC=C1OCC1=CC=CC=N1 GTLHFFSIEBUGAS-UHFFFAOYSA-N 0.000 claims 1
- VDCRSOSLUISLAL-UHFFFAOYSA-N 2-[2-[[4-[3-chloro-4-(pyridin-2-ylmethoxy)anilino]-1h-pyrazolo[3,4-d]pyrimidin-3-yl]oxy]ethyl-methylamino]ethanol Chemical compound C=12C(OCCN(CCO)C)=NNC2=NC=NC=1NC(C=C1Cl)=CC=C1OCC1=CC=CC=N1 VDCRSOSLUISLAL-UHFFFAOYSA-N 0.000 claims 1
- HQKWSNMALVWOBX-UHFFFAOYSA-N 2-[2-[[4-[3-chloro-4-(pyridin-2-ylmethoxy)anilino]-1h-pyrazolo[3,4-d]pyrimidin-3-yl]oxy]ethyl]isoindole-1,3-dione Chemical compound ClC1=CC(NC=2C=3C(OCCN4C(C5=CC=CC=C5C4=O)=O)=NNC=3N=CN=2)=CC=C1OCC1=CC=CC=N1 HQKWSNMALVWOBX-UHFFFAOYSA-N 0.000 claims 1
- GMOPIFJDXGFMTI-UHFFFAOYSA-N 2-[2-[[4-[3-chloro-4-(pyridin-2-ylmethoxy)anilino]-1h-pyrazolo[3,4-d]pyrimidin-3-yl]oxy]ethylamino]ethanol Chemical compound C=12C(OCCNCCO)=NNC2=NC=NC=1NC(C=C1Cl)=CC=C1OCC1=CC=CC=N1 GMOPIFJDXGFMTI-UHFFFAOYSA-N 0.000 claims 1
- VCBCMTRNJOCIDN-UHFFFAOYSA-N 2-[[4-(3-methyl-4-phenylmethoxyanilino)-1h-pyrazolo[3,4-d]pyrimidin-3-yl]oxy]ethanol Chemical compound CC1=CC(NC=2C=3C(OCCO)=NNC=3N=CN=2)=CC=C1OCC1=CC=CC=C1 VCBCMTRNJOCIDN-UHFFFAOYSA-N 0.000 claims 1
- DWQMEVYRCUVXHE-UHFFFAOYSA-N 2-[[4-(3-methyl-4-phenylmethoxyanilino)-1h-pyrazolo[3,4-d]pyrimidin-3-yl]oxy]ethyl methanesulfonate Chemical compound CC1=CC(NC=2C=3C(OCCOS(C)(=O)=O)=NNC=3N=CN=2)=CC=C1OCC1=CC=CC=C1 DWQMEVYRCUVXHE-UHFFFAOYSA-N 0.000 claims 1
- UBCJSZANJDXNGO-UHFFFAOYSA-N 2-[[4-[3-chloro-4-(6-methylpyridin-3-yl)oxyanilino]-1h-pyrazolo[3,4-d]pyrimidin-3-yl]oxy]ethanol Chemical compound C1=NC(C)=CC=C1OC(C(=C1)Cl)=CC=C1NC1=NC=NC2=C1C(OCCO)=NN2 UBCJSZANJDXNGO-UHFFFAOYSA-N 0.000 claims 1
- BVXBBIZFISJCMB-UHFFFAOYSA-N 2-[[4-[3-chloro-4-(pyridin-2-ylmethoxy)anilino]-1h-pyrazolo[3,4-d]pyrimidin-3-yl]oxy]ethanol Chemical compound C=12C(OCCO)=NNC2=NC=NC=1NC(C=C1Cl)=CC=C1OCC1=CC=CC=N1 BVXBBIZFISJCMB-UHFFFAOYSA-N 0.000 claims 1
- SKBXFJWEVNAXDN-UHFFFAOYSA-N 2-[[4-[3-chloro-4-[(3-fluorophenyl)methoxy]anilino]-1h-pyrazolo[3,4-d]pyrimidin-3-yl]oxy]ethanol Chemical compound C=12C(OCCO)=NNC2=NC=NC=1NC(C=C1Cl)=CC=C1OCC1=CC=CC(F)=C1 SKBXFJWEVNAXDN-UHFFFAOYSA-N 0.000 claims 1
- QQKPLRVQGDAHMD-UHFFFAOYSA-N 2-[[4-[3-ethyl-4-(pyridin-2-ylmethoxy)anilino]-1h-pyrazolo[3,4-d]pyrimidin-3-yl]oxy]ethanol Chemical compound CCC1=CC(NC=2C=3C(OCCO)=NNC=3N=CN=2)=CC=C1OCC1=CC=CC=N1 QQKPLRVQGDAHMD-UHFFFAOYSA-N 0.000 claims 1
- LUUWYBPINNTPHS-UHFFFAOYSA-N 2-[[4-[3-ethyl-4-(pyridin-2-ylmethoxy)anilino]-1h-pyrazolo[3,4-d]pyrimidin-3-yl]oxy]ethyl methanesulfonate Chemical compound CCC1=CC(NC=2C=3C(OCCOS(C)(=O)=O)=NNC=3N=CN=2)=CC=C1OCC1=CC=CC=N1 LUUWYBPINNTPHS-UHFFFAOYSA-N 0.000 claims 1
- NUVBYFJZLGNHNV-UHFFFAOYSA-N 2-[[4-[3-fluoro-4-(6-methylpyridin-3-yl)oxyanilino]-1h-pyrazolo[3,4-d]pyrimidin-3-yl]oxy]ethanol Chemical compound C1=NC(C)=CC=C1OC(C(=C1)F)=CC=C1NC1=NC=NC2=C1C(OCCO)=NN2 NUVBYFJZLGNHNV-UHFFFAOYSA-N 0.000 claims 1
- LSPCWHXKKSISSZ-UHFFFAOYSA-N 2-[[4-[3-fluoro-4-(6-methylpyridin-3-yl)oxyanilino]-1h-pyrazolo[3,4-d]pyrimidin-3-yl]oxy]ethyl methanesulfonate Chemical compound C1=NC(C)=CC=C1OC(C(=C1)F)=CC=C1NC1=NC=NC2=C1C(OCCOS(C)(=O)=O)=NN2 LSPCWHXKKSISSZ-UHFFFAOYSA-N 0.000 claims 1
- MUFDVQWYYRRQAE-UHFFFAOYSA-N 2-[[4-[3-methoxy-4-(pyridin-2-ylmethoxy)anilino]-1h-pyrazolo[3,4-d]pyrimidin-3-yl]oxy]ethanol Chemical compound COC1=CC(NC=2C=3C(OCCO)=NNC=3N=CN=2)=CC=C1OCC1=CC=CC=N1 MUFDVQWYYRRQAE-UHFFFAOYSA-N 0.000 claims 1
- ZAZCSLJDXBQHGH-UHFFFAOYSA-N 2-[[4-[3-methoxy-4-(pyridin-2-ylmethoxy)anilino]-1h-pyrazolo[3,4-d]pyrimidin-3-yl]oxy]ethyl methanesulfonate Chemical compound COC1=CC(NC=2C=3C(OCCOS(C)(=O)=O)=NNC=3N=CN=2)=CC=C1OCC1=CC=CC=N1 ZAZCSLJDXBQHGH-UHFFFAOYSA-N 0.000 claims 1
- OJTJMWFGMBUKOC-UHFFFAOYSA-N 2-[[4-[3-methyl-4-(6-methylpyridin-3-yl)oxyanilino]-1h-pyrazolo[3,4-d]pyrimidin-3-yl]oxy]ethanol Chemical compound C1=NC(C)=CC=C1OC(C(=C1)C)=CC=C1NC1=NC=NC2=C1C(OCCO)=NN2 OJTJMWFGMBUKOC-UHFFFAOYSA-N 0.000 claims 1
- GGEVOJHFGNWZGI-UHFFFAOYSA-N 2-[[4-[3-methyl-4-(pyridin-2-ylmethoxy)anilino]-1h-pyrazolo[3,4-d]pyrimidin-3-yl]oxy]ethanol Chemical compound CC1=CC(NC=2C=3C(OCCO)=NNC=3N=CN=2)=CC=C1OCC1=CC=CC=N1 GGEVOJHFGNWZGI-UHFFFAOYSA-N 0.000 claims 1
- JTQWIJMEIWERSG-UHFFFAOYSA-N 2-[[4-[4-[(3-fluorophenyl)methoxy]-3-methoxyanilino]-1h-pyrazolo[3,4-d]pyrimidin-3-yl]oxy]ethanol Chemical compound COC1=CC(NC=2C=3C(OCCO)=NNC=3N=CN=2)=CC=C1OCC1=CC=CC(F)=C1 JTQWIJMEIWERSG-UHFFFAOYSA-N 0.000 claims 1
- UZLMATJGCNFKIK-UHFFFAOYSA-N 2-[[4-[4-[(3-fluorophenyl)methoxy]-3-methoxyanilino]-1h-pyrazolo[3,4-d]pyrimidin-3-yl]oxy]ethyl methanesulfonate Chemical compound COC1=CC(NC=2C=3C(OCCOS(C)(=O)=O)=NNC=3N=CN=2)=CC=C1OCC1=CC=CC(F)=C1 UZLMATJGCNFKIK-UHFFFAOYSA-N 0.000 claims 1
- LOPQEHBTGQRZFU-UHFFFAOYSA-N 2-[[4-[4-[(3-fluorophenyl)methoxy]-3-methylanilino]-1h-pyrazolo[3,4-d]pyrimidin-3-yl]oxy]ethanol Chemical compound CC1=CC(NC=2C=3C(OCCO)=NNC=3N=CN=2)=CC=C1OCC1=CC=CC(F)=C1 LOPQEHBTGQRZFU-UHFFFAOYSA-N 0.000 claims 1
- KPWMJDMLPWEYRW-UHFFFAOYSA-N 2-[[4-[4-[(3-fluorophenyl)methoxy]-3-methylanilino]-1h-pyrazolo[3,4-d]pyrimidin-3-yl]oxy]ethyl methanesulfonate Chemical compound CC1=CC(NC=2C=3C(OCCOS(C)(=O)=O)=NNC=3N=CN=2)=CC=C1OCC1=CC=CC(F)=C1 KPWMJDMLPWEYRW-UHFFFAOYSA-N 0.000 claims 1
- IMRWILPUOVGIMU-UHFFFAOYSA-N 2-bromopyridine Chemical compound BrC1=CC=CC=N1 IMRWILPUOVGIMU-UHFFFAOYSA-N 0.000 claims 1
- GELVZYOEQVJIRR-UHFFFAOYSA-N 2-chloropyrazine Chemical compound ClC1=CN=CC=N1 GELVZYOEQVJIRR-UHFFFAOYSA-N 0.000 claims 1
- UNCQVRBWJWWJBF-UHFFFAOYSA-N 2-chloropyrimidine Chemical compound ClC1=NC=CC=N1 UNCQVRBWJWWJBF-UHFFFAOYSA-N 0.000 claims 1
- PNRGWUZKSFCRFE-UHFFFAOYSA-N 3-(2-aminoethoxy)-n-[3-chloro-4-(pyridin-2-ylmethoxy)phenyl]-1h-pyrazolo[3,4-d]pyrimidin-4-amine Chemical compound C=12C(OCCN)=NNC2=NC=NC=1NC(C=C1Cl)=CC=C1OCC1=CC=CC=N1 PNRGWUZKSFCRFE-UHFFFAOYSA-N 0.000 claims 1
- DPHAWCPZXZKKKL-UHFFFAOYSA-N 3-(2-chloroethoxy)-n-[3-chloro-4-(6-methylpyridin-3-yl)oxyphenyl]-1h-pyrazolo[3,4-d]pyrimidin-4-amine Chemical compound C1=NC(C)=CC=C1OC(C(=C1)Cl)=CC=C1NC1=NC=NC2=C1C(OCCCl)=NN2 DPHAWCPZXZKKKL-UHFFFAOYSA-N 0.000 claims 1
- WXMXECCBNSLQIU-UHFFFAOYSA-N 3-(2-chloroethoxy)-n-[3-chloro-4-(pyridin-2-ylmethoxy)phenyl]-1h-pyrazolo[3,4-d]pyrimidin-4-amine Chemical compound C=12C(OCCCl)=NNC2=NC=NC=1NC(C=C1Cl)=CC=C1OCC1=CC=CC=N1 WXMXECCBNSLQIU-UHFFFAOYSA-N 0.000 claims 1
- OWSHRKZKSBBPQR-UHFFFAOYSA-N 3-(2-chloroethoxy)-n-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-1h-pyrazolo[3,4-d]pyrimidin-4-amine Chemical compound FC1=CC=CC(COC=2C(=CC(NC=3C=4C(OCCCl)=NNC=4N=CN=3)=CC=2)Cl)=C1 OWSHRKZKSBBPQR-UHFFFAOYSA-N 0.000 claims 1
- PXFUEIKNCSVPEY-UHFFFAOYSA-N 3-(2-chloroethoxy)-n-[3-methyl-4-(6-methylpyridin-3-yl)oxyphenyl]-1h-pyrazolo[3,4-d]pyrimidin-4-amine Chemical compound C1=NC(C)=CC=C1OC(C(=C1)C)=CC=C1NC1=NC=NC2=C1C(OCCCl)=NN2 PXFUEIKNCSVPEY-UHFFFAOYSA-N 0.000 claims 1
- YHIZVMKYWYTWQK-UHFFFAOYSA-N 3-(2-chloroethoxy)-n-[3-methyl-4-(pyridin-2-ylmethoxy)phenyl]-1h-pyrazolo[3,4-d]pyrimidin-4-amine Chemical compound CC1=CC(NC=2C=3C(OCCCl)=NNC=3N=CN=2)=CC=C1OCC1=CC=CC=N1 YHIZVMKYWYTWQK-UHFFFAOYSA-N 0.000 claims 1
- FBCHCJDZNHLISS-UHFFFAOYSA-N 3-(3-chloropropoxy)-n-[3-chloro-4-(pyridin-2-ylmethoxy)phenyl]-1h-pyrazolo[3,4-d]pyrimidin-4-amine Chemical compound C=12C(OCCCCl)=NNC2=NC=NC=1NC(C=C1Cl)=CC=C1OCC1=CC=CC=N1 FBCHCJDZNHLISS-UHFFFAOYSA-N 0.000 claims 1
- VETWRYZUXGQTHB-UHFFFAOYSA-N 3-[2-(4-ethylpiperazin-1-yl)ethoxy]-n-(3-methyl-4-phenylmethoxyphenyl)-1h-pyrazolo[3,4-d]pyrimidin-4-amine Chemical compound C1CN(CC)CCN1CCOC1=NNC2=NC=NC(NC=3C=C(C)C(OCC=4C=CC=CC=4)=CC=3)=C12 VETWRYZUXGQTHB-UHFFFAOYSA-N 0.000 claims 1
- MBMCUSPDBVTJNF-UHFFFAOYSA-N 3-[2-(4-ethylpiperazin-1-yl)ethoxy]-n-[4-[(3-fluorophenyl)methoxy]-3-methylphenyl]-1h-pyrazolo[3,4-d]pyrimidin-4-amine Chemical compound C1CN(CC)CCN1CCOC1=NNC2=NC=NC(NC=3C=C(C)C(OCC=4C=C(F)C=CC=4)=CC=3)=C12 MBMCUSPDBVTJNF-UHFFFAOYSA-N 0.000 claims 1
- YJTCKKYREZKMBL-UHFFFAOYSA-N 3-[2-(4-methoxypiperidin-1-yl)ethoxy]-n-(3-methyl-4-phenylmethoxyphenyl)-1h-pyrazolo[3,4-d]pyrimidin-4-amine Chemical compound C1CC(OC)CCN1CCOC1=NNC2=NC=NC(NC=3C=C(C)C(OCC=4C=CC=CC=4)=CC=3)=C12 YJTCKKYREZKMBL-UHFFFAOYSA-N 0.000 claims 1
- IUVOKGOLFAETBO-UHFFFAOYSA-N 3-[2-(4-methylpiperazin-1-yl)ethoxy]-n-[3-methyl-4-(pyridin-2-ylmethoxy)phenyl]-1h-pyrazolo[3,4-d]pyrimidin-4-amine Chemical compound C1CN(C)CCN1CCOC1=NNC2=NC=NC(NC=3C=C(C)C(OCC=4N=CC=CC=4)=CC=3)=C12 IUVOKGOLFAETBO-UHFFFAOYSA-N 0.000 claims 1
- GGPZIJVTEKQBEM-UHFFFAOYSA-N 3-[2-[[4-[3-chloro-4-(pyridin-2-ylmethoxy)anilino]-1h-pyrazolo[3,4-d]pyrimidin-3-yl]oxy]ethyl]-1,3-oxazolidin-2-one Chemical compound C=1C=C(OCC=2N=CC=CC=2)C(Cl)=CC=1NC(C1=2)=NC=NC=2NN=C1OCCN1CCOC1=O GGPZIJVTEKQBEM-UHFFFAOYSA-N 0.000 claims 1
- NZTUKBQQIGTFSG-UHFFFAOYSA-N 3-[[4-[3-chloro-4-(pyridin-2-ylmethoxy)anilino]-1h-pyrazolo[3,4-d]pyrimidin-3-yl]oxy]propan-1-ol Chemical compound C=12C(OCCCO)=NNC2=NC=NC=1NC(C=C1Cl)=CC=C1OCC1=CC=CC=N1 NZTUKBQQIGTFSG-UHFFFAOYSA-N 0.000 claims 1
- IBWYHNOFSKJKKY-UHFFFAOYSA-N 3-chloropyridazine Chemical compound ClC1=CC=CN=N1 IBWYHNOFSKJKKY-UHFFFAOYSA-N 0.000 claims 1
- MTHWFHQFVTUUMP-UHFFFAOYSA-N 4-[2-[[4-[3-chloro-4-(pyridin-2-ylmethoxy)anilino]-1h-pyrazolo[3,4-d]pyrimidin-3-yl]oxy]ethyl]morpholin-3-one Chemical compound C=1C=C(OCC=2N=CC=CC=2)C(Cl)=CC=1NC(C1=2)=NC=NC=2NN=C1OCCN1CCOCC1=O MTHWFHQFVTUUMP-UHFFFAOYSA-N 0.000 claims 1
- KLKJUWZHEZFRDM-UHFFFAOYSA-N 4-[2-[[4-[3-chloro-4-(pyridin-2-ylmethoxy)anilino]-1h-pyrazolo[3,4-d]pyrimidin-3-yl]oxy]ethyl]piperazin-2-one Chemical compound C=1C=C(OCC=2N=CC=CC=2)C(Cl)=CC=1NC(C1=2)=NC=NC=2NN=C1OCCN1CCNC(=O)C1 KLKJUWZHEZFRDM-UHFFFAOYSA-N 0.000 claims 1
- CMYJXNIXVHLTGH-UHFFFAOYSA-N 4-[2-[[4-[3-methyl-4-(6-methylpyridin-3-yl)oxyanilino]-1h-pyrazolo[3,4-d]pyrimidin-3-yl]oxy]ethyl]piperazin-2-one Chemical compound C1=NC(C)=CC=C1OC(C(=C1)C)=CC=C1NC1=NC=NC2=C1C(OCCN1CC(=O)NCC1)=NN2 CMYJXNIXVHLTGH-UHFFFAOYSA-N 0.000 claims 1
- BSDGZUDFPKIYQG-UHFFFAOYSA-N 4-bromopyridine Chemical compound BrC1=CC=NC=C1 BSDGZUDFPKIYQG-UHFFFAOYSA-N 0.000 claims 1
- DBPKMSBWOKAKLA-UHFFFAOYSA-N 4-chloropyrimidine Chemical compound ClC1=CC=NC=N1 DBPKMSBWOKAKLA-UHFFFAOYSA-N 0.000 claims 1
- 125000000339 4-pyridyl group Chemical group N1=C([H])C([H])=C([*])C([H])=C1[H] 0.000 claims 1
- 241001024304 Mino Species 0.000 claims 1
- 238000006751 Mitsunobu reaction Methods 0.000 claims 1
- 206010028980 Neoplasm Diseases 0.000 claims 1
- 241001377010 Pila Species 0.000 claims 1
- WKJQZZUUVRGDNN-QGZVFWFLSA-N [(2r)-1-[2-[[4-[3-chloro-4-(6-methylpyridin-3-yl)oxyanilino]-1h-pyrazolo[3,4-d]pyrimidin-3-yl]oxy]ethyl]pyrrolidin-2-yl]methanol Chemical compound C1=NC(C)=CC=C1OC(C(=C1)Cl)=CC=C1NC1=NC=NC2=C1C(OCCN1[C@H](CCC1)CO)=NN2 WKJQZZUUVRGDNN-QGZVFWFLSA-N 0.000 claims 1
- SUFDUIJMLDPZCC-LJQANCHMSA-N [(2r)-1-[2-[[4-[3-methyl-4-(6-methylpyridin-3-yl)oxyanilino]-1h-pyrazolo[3,4-d]pyrimidin-3-yl]oxy]ethyl]pyrrolidin-2-yl]methanol Chemical compound C1=NC(C)=CC=C1OC(C(=C1)C)=CC=C1NC1=NC=NC2=C1C(OCCN1[C@H](CCC1)CO)=NN2 SUFDUIJMLDPZCC-LJQANCHMSA-N 0.000 claims 1
- GJOLHJIOHKNVAV-OAQYLSRUSA-N [(2r)-1-[2-[[4-[4-[(3-fluorophenyl)methoxy]-3-methylanilino]-1h-pyrazolo[3,4-d]pyrimidin-3-yl]oxy]ethyl]pyrrolidin-2-yl]methanol Chemical compound C=1C=C(OCC=2C=C(F)C=CC=2)C(C)=CC=1NC(C1=2)=NC=NC=2NN=C1OCCN1CCC[C@@H]1CO GJOLHJIOHKNVAV-OAQYLSRUSA-N 0.000 claims 1
- SUFDUIJMLDPZCC-IBGZPJMESA-N [(2s)-1-[2-[[4-[3-methyl-4-(6-methylpyridin-3-yl)oxyanilino]-1h-pyrazolo[3,4-d]pyrimidin-3-yl]oxy]ethyl]pyrrolidin-2-yl]methanol Chemical compound C1=NC(C)=CC=C1OC(C(=C1)C)=CC=C1NC1=NC=NC2=C1C(OCCN1[C@@H](CCC1)CO)=NN2 SUFDUIJMLDPZCC-IBGZPJMESA-N 0.000 claims 1
- 125000002947 alkylene group Chemical group 0.000 claims 1
- 239000002246 antineoplastic agent Substances 0.000 claims 1
- 201000011510 cancer Diseases 0.000 claims 1
- 125000004432 carbon atom Chemical group C* 0.000 claims 1
- 239000003085 diluting agent Substances 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- UNFTUPUDNYZENT-UHFFFAOYSA-N n-(3-methyl-4-phenylmethoxyphenyl)-3-(2-morpholin-4-ylethoxy)-1h-pyrazolo[3,4-d]pyrimidin-4-amine Chemical compound C=1C=C(OCC=2C=CC=CC=2)C(C)=CC=1NC(C1=2)=NC=NC=2NN=C1OCCN1CCOCC1 UNFTUPUDNYZENT-UHFFFAOYSA-N 0.000 claims 1
- ASQSYGKFXWXPAL-UHFFFAOYSA-N n-(3-methyl-4-phenylmethoxyphenyl)-3-[2-(1,4-oxazepan-4-yl)ethoxy]-1h-pyrazolo[3,4-d]pyrimidin-4-amine Chemical compound C=1C=C(OCC=2C=CC=CC=2)C(C)=CC=1NC(C1=2)=NC=NC=2NN=C1OCCN1CCCOCC1 ASQSYGKFXWXPAL-UHFFFAOYSA-N 0.000 claims 1
- JOVNZQWMNRQTMZ-UHFFFAOYSA-N n-(3-methyl-4-phenylmethoxyphenyl)-3-[2-(4-methylpiperazin-1-yl)ethoxy]-1h-pyrazolo[3,4-d]pyrimidin-4-amine Chemical compound C1CN(C)CCN1CCOC1=NNC2=NC=NC(NC=3C=C(C)C(OCC=4C=CC=CC=4)=CC=3)=C12 JOVNZQWMNRQTMZ-UHFFFAOYSA-N 0.000 claims 1
- SZZYSRRMVBILNX-UHFFFAOYSA-N n-[2-[[4-[3-chloro-4-(pyridin-2-ylmethoxy)anilino]-1h-pyrazolo[3,4-d]pyrimidin-3-yl]oxy]ethyl]-2-hydroxy-n-methylacetamide Chemical compound C=12C(OCCN(C)C(=O)CO)=NNC2=NC=NC=1NC(C=C1Cl)=CC=C1OCC1=CC=CC=N1 SZZYSRRMVBILNX-UHFFFAOYSA-N 0.000 claims 1
- QUKLGRGKPOOPHH-UHFFFAOYSA-N n-[2-[[4-[3-chloro-4-(pyridin-2-ylmethoxy)anilino]-1h-pyrazolo[3,4-d]pyrimidin-3-yl]oxy]ethyl]-n-(2-hydroxyethyl)acetamide Chemical compound C=12C(OCCN(CCO)C(=O)C)=NNC2=NC=NC=1NC(C=C1Cl)=CC=C1OCC1=CC=CC=N1 QUKLGRGKPOOPHH-UHFFFAOYSA-N 0.000 claims 1
- GEAQACPFDLMFSN-UHFFFAOYSA-N n-[2-[[4-[3-chloro-4-[(3-fluorophenyl)methoxy]anilino]-1h-pyrazolo[3,4-d]pyrimidin-3-yl]oxy]ethyl]-2-hydroxy-n-methylacetamide Chemical compound C=12C(OCCN(C)C(=O)CO)=NNC2=NC=NC=1NC(C=C1Cl)=CC=C1OCC1=CC=CC(F)=C1 GEAQACPFDLMFSN-UHFFFAOYSA-N 0.000 claims 1
- JXOZPJLYHWHBIZ-UHFFFAOYSA-N n-[3-chloro-4-(6-methylpyridin-3-yl)oxyphenyl]-3-(2-morpholin-4-ylethoxy)-1h-pyrazolo[3,4-d]pyrimidin-4-amine Chemical compound C1=NC(C)=CC=C1OC(C(=C1)Cl)=CC=C1NC1=NC=NC2=C1C(OCCN1CCOCC1)=NN2 JXOZPJLYHWHBIZ-UHFFFAOYSA-N 0.000 claims 1
- QIWBCYHPAIIUDF-UHFFFAOYSA-N n-[3-chloro-4-(6-methylpyridin-3-yl)oxyphenyl]-3-(2-pyrrolidin-1-ylethoxy)-1h-pyrazolo[3,4-d]pyrimidin-4-amine Chemical compound C1=NC(C)=CC=C1OC(C(=C1)Cl)=CC=C1NC1=NC=NC2=C1C(OCCN1CCCC1)=NN2 QIWBCYHPAIIUDF-UHFFFAOYSA-N 0.000 claims 1
- WZLDFUQYHUCVND-UHFFFAOYSA-N n-[3-chloro-4-(6-methylpyridin-3-yl)oxyphenyl]-3-[2-(4-cyclopropylpiperazin-1-yl)ethoxy]-1h-pyrazolo[3,4-d]pyrimidin-4-amine Chemical compound C1=NC(C)=CC=C1OC(C(=C1)Cl)=CC=C1NC1=NC=NC2=C1C(OCCN1CCN(CC1)C1CC1)=NN2 WZLDFUQYHUCVND-UHFFFAOYSA-N 0.000 claims 1
- JVMVIBWYSSVZRT-UHFFFAOYSA-N n-[3-chloro-4-(6-methylpyridin-3-yl)oxyphenyl]-3-[2-(4-ethylpiperazin-1-yl)ethoxy]-1h-pyrazolo[3,4-d]pyrimidin-4-amine Chemical compound C1CN(CC)CCN1CCOC1=NNC2=NC=NC(NC=3C=C(Cl)C(OC=4C=NC(C)=CC=4)=CC=3)=C12 JVMVIBWYSSVZRT-UHFFFAOYSA-N 0.000 claims 1
- AXPGBKRKGXVCLA-UHFFFAOYSA-N n-[3-chloro-4-(6-methylpyridin-3-yl)oxyphenyl]-3-[2-(4-fluoropiperidin-1-yl)ethoxy]-1h-pyrazolo[3,4-d]pyrimidin-4-amine Chemical compound C1=NC(C)=CC=C1OC(C(=C1)Cl)=CC=C1NC1=NC=NC2=C1C(OCCN1CCC(F)CC1)=NN2 AXPGBKRKGXVCLA-UHFFFAOYSA-N 0.000 claims 1
- WLXWMWRAGQAHKG-UHFFFAOYSA-N n-[3-chloro-4-(6-methylpyridin-3-yl)oxyphenyl]-3-[2-(4-methylpiperazin-1-yl)ethoxy]-1h-pyrazolo[3,4-d]pyrimidin-4-amine Chemical compound C1CN(C)CCN1CCOC1=NNC2=NC=NC(NC=3C=C(Cl)C(OC=4C=NC(C)=CC=4)=CC=3)=C12 WLXWMWRAGQAHKG-UHFFFAOYSA-N 0.000 claims 1
- AAHUNSQSRKMUNG-UHFFFAOYSA-N n-[3-chloro-4-(6-methylpyridin-3-yl)oxyphenyl]-3-[2-(4-propan-2-ylpiperazin-1-yl)ethoxy]-1h-pyrazolo[3,4-d]pyrimidin-4-amine Chemical compound C1CN(C(C)C)CCN1CCOC1=NNC2=NC=NC(NC=3C=C(Cl)C(OC=4C=NC(C)=CC=4)=CC=3)=C12 AAHUNSQSRKMUNG-UHFFFAOYSA-N 0.000 claims 1
- SOUZMKSRWWAKTO-GOSISDBHSA-N n-[3-chloro-4-(6-methylpyridin-3-yl)oxyphenyl]-3-[2-[(2r)-2-(methoxymethyl)pyrrolidin-1-yl]ethoxy]-1h-pyrazolo[3,4-d]pyrimidin-4-amine Chemical compound COC[C@H]1CCCN1CCOC1=NNC2=NC=NC(NC=3C=C(Cl)C(OC=4C=NC(C)=CC=4)=CC=3)=C12 SOUZMKSRWWAKTO-GOSISDBHSA-N 0.000 claims 1
- GOWVVIDXCJWUFJ-UHFFFAOYSA-N n-[3-chloro-4-(pyridin-2-ylmethoxy)phenyl]-3-(2-morpholin-4-ylethoxy)-1h-pyrazolo[3,4-d]pyrimidin-4-amine Chemical compound C=1C=C(OCC=2N=CC=CC=2)C(Cl)=CC=1NC(C1=2)=NC=NC=2NN=C1OCCN1CCOCC1 GOWVVIDXCJWUFJ-UHFFFAOYSA-N 0.000 claims 1
- CAZQZPUZMIOJCR-UHFFFAOYSA-N n-[3-chloro-4-(pyridin-2-ylmethoxy)phenyl]-3-(2-piperazin-1-ylethoxy)-1h-pyrazolo[3,4-d]pyrimidin-4-amine Chemical compound C=1C=C(OCC=2N=CC=CC=2)C(Cl)=CC=1NC(C1=2)=NC=NC=2NN=C1OCCN1CCNCC1 CAZQZPUZMIOJCR-UHFFFAOYSA-N 0.000 claims 1
- KOQXIMMOAUHZFN-UHFFFAOYSA-N n-[3-chloro-4-(pyridin-2-ylmethoxy)phenyl]-3-(2-pyrrolidin-1-ylethoxy)-1h-pyrazolo[3,4-d]pyrimidin-4-amine Chemical compound C=1C=C(OCC=2N=CC=CC=2)C(Cl)=CC=1NC(C1=2)=NC=NC=2NN=C1OCCN1CCCC1 KOQXIMMOAUHZFN-UHFFFAOYSA-N 0.000 claims 1
- HYWZCMMMRGRRRF-UHFFFAOYSA-N n-[3-chloro-4-(pyridin-2-ylmethoxy)phenyl]-3-(3-morpholin-4-ylpropoxy)-1h-pyrazolo[3,4-d]pyrimidin-4-amine Chemical compound C=1C=C(OCC=2N=CC=CC=2)C(Cl)=CC=1NC(C1=2)=NC=NC=2NN=C1OCCCN1CCOCC1 HYWZCMMMRGRRRF-UHFFFAOYSA-N 0.000 claims 1
- HMNKCAKJQMTJKY-UHFFFAOYSA-N n-[3-chloro-4-(pyridin-2-ylmethoxy)phenyl]-3-(3-pyrrolidin-1-ylpropoxy)-1h-pyrazolo[3,4-d]pyrimidin-4-amine Chemical compound C=1C=C(OCC=2N=CC=CC=2)C(Cl)=CC=1NC(C1=2)=NC=NC=2NN=C1OCCCN1CCCC1 HMNKCAKJQMTJKY-UHFFFAOYSA-N 0.000 claims 1
- VURXBSLXUBBGQE-UHFFFAOYSA-N n-[3-chloro-4-(pyridin-2-ylmethoxy)phenyl]-3-[2-(1,4-oxazepan-4-yl)ethoxy]-1h-pyrazolo[3,4-d]pyrimidin-4-amine Chemical compound C=1C=C(OCC=2N=CC=CC=2)C(Cl)=CC=1NC(C1=2)=NC=NC=2NN=C1OCCN1CCCOCC1 VURXBSLXUBBGQE-UHFFFAOYSA-N 0.000 claims 1
- QDOLMCSPGVWMFW-UHFFFAOYSA-N n-[3-chloro-4-(pyridin-2-ylmethoxy)phenyl]-3-[2-(4-ethylpiperazin-1-yl)ethoxy]-1h-pyrazolo[3,4-d]pyrimidin-4-amine Chemical compound C1CN(CC)CCN1CCOC1=NNC2=NC=NC(NC=3C=C(Cl)C(OCC=4N=CC=CC=4)=CC=3)=C12 QDOLMCSPGVWMFW-UHFFFAOYSA-N 0.000 claims 1
- KYLCGDSKIUQKFX-UHFFFAOYSA-N n-[3-chloro-4-(pyridin-2-ylmethoxy)phenyl]-3-[2-(4-fluoropiperidin-1-yl)ethoxy]-1h-pyrazolo[3,4-d]pyrimidin-4-amine Chemical compound C1CC(F)CCN1CCOC1=NNC2=NC=NC(NC=3C=C(Cl)C(OCC=4N=CC=CC=4)=CC=3)=C12 KYLCGDSKIUQKFX-UHFFFAOYSA-N 0.000 claims 1
- BZUIGXZUUGQBLL-UHFFFAOYSA-N n-[3-chloro-4-(pyridin-2-ylmethoxy)phenyl]-3-[2-(4-methylpiperazin-1-yl)ethoxy]-1h-pyrazolo[3,4-d]pyrimidin-4-amine Chemical compound C1CN(C)CCN1CCOC1=NNC2=NC=NC(NC=3C=C(Cl)C(OCC=4N=CC=CC=4)=CC=3)=C12 BZUIGXZUUGQBLL-UHFFFAOYSA-N 0.000 claims 1
- VEWLBJRDDQOQHC-UHFFFAOYSA-N n-[3-chloro-4-(pyridin-2-ylmethoxy)phenyl]-3-[2-(4-propan-2-ylpiperazin-1-yl)ethoxy]-1h-pyrazolo[3,4-d]pyrimidin-4-amine Chemical compound C1CN(C(C)C)CCN1CCOC1=NNC2=NC=NC(NC=3C=C(Cl)C(OCC=4N=CC=CC=4)=CC=3)=C12 VEWLBJRDDQOQHC-UHFFFAOYSA-N 0.000 claims 1
- MPSMEEDGQBLMNI-UHFFFAOYSA-N n-[3-chloro-4-(pyridin-2-ylmethoxy)phenyl]-3-[2-(methylamino)ethoxy]-1h-pyrazolo[3,4-d]pyrimidin-4-amine Chemical compound C=12C(OCCNC)=NNC2=NC=NC=1NC(C=C1Cl)=CC=C1OCC1=CC=CC=N1 MPSMEEDGQBLMNI-UHFFFAOYSA-N 0.000 claims 1
- BERLNDGSHCXVKP-UHFFFAOYSA-N n-[3-chloro-4-(pyridin-2-ylmethoxy)phenyl]-3-[3-(4-methylpiperazin-1-yl)propoxy]-1h-pyrazolo[3,4-d]pyrimidin-4-amine Chemical compound C1CN(C)CCN1CCCOC1=NNC2=NC=NC(NC=3C=C(Cl)C(OCC=4N=CC=CC=4)=CC=3)=C12 BERLNDGSHCXVKP-UHFFFAOYSA-N 0.000 claims 1
- UUHZEWZYPYVUKW-UHFFFAOYSA-N n-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-3-(2-pyrrolidin-1-ylethoxy)-1h-pyrazolo[3,4-d]pyrimidin-4-amine Chemical compound FC1=CC=CC(COC=2C(=CC(NC=3C=4C(OCCN5CCCC5)=NNC=4N=CN=3)=CC=2)Cl)=C1 UUHZEWZYPYVUKW-UHFFFAOYSA-N 0.000 claims 1
- SLYDNKVLPRXSBW-UHFFFAOYSA-N n-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-3-[2-(4-methylpiperazin-1-yl)ethoxy]-1h-pyrazolo[3,4-d]pyrimidin-4-amine Chemical compound C1CN(C)CCN1CCOC1=NNC2=NC=NC(NC=3C=C(Cl)C(OCC=4C=C(F)C=CC=4)=CC=3)=C12 SLYDNKVLPRXSBW-UHFFFAOYSA-N 0.000 claims 1
- IKXMFUGPORBDCU-UHFFFAOYSA-N n-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-3-[2-(methylamino)ethoxy]-1h-pyrazolo[3,4-d]pyrimidin-4-amine Chemical compound C=12C(OCCNC)=NNC2=NC=NC=1NC(C=C1Cl)=CC=C1OCC1=CC=CC(F)=C1 IKXMFUGPORBDCU-UHFFFAOYSA-N 0.000 claims 1
- YKRIAQZYXBQQGD-UHFFFAOYSA-N n-[3-ethyl-4-(pyridin-2-ylmethoxy)phenyl]-3-(2-morpholin-4-ylethoxy)-1h-pyrazolo[3,4-d]pyrimidin-4-amine Chemical compound C=1C=C(OCC=2N=CC=CC=2)C(CC)=CC=1NC(C1=2)=NC=NC=2NN=C1OCCN1CCOCC1 YKRIAQZYXBQQGD-UHFFFAOYSA-N 0.000 claims 1
- BDHLBNXTIUYNJR-UHFFFAOYSA-N n-[3-ethyl-4-(pyridin-2-ylmethoxy)phenyl]-3-(2-pyrrolidin-1-ylethoxy)-1h-pyrazolo[3,4-d]pyrimidin-4-amine Chemical compound C=1C=C(OCC=2N=CC=CC=2)C(CC)=CC=1NC(C1=2)=NC=NC=2NN=C1OCCN1CCCC1 BDHLBNXTIUYNJR-UHFFFAOYSA-N 0.000 claims 1
- GHACSHWDWWMCKR-UHFFFAOYSA-N n-[3-ethyl-4-(pyridin-2-ylmethoxy)phenyl]-3-[2-(4-methylpiperazin-1-yl)ethoxy]-1h-pyrazolo[3,4-d]pyrimidin-4-amine Chemical compound C=1C=C(OCC=2N=CC=CC=2)C(CC)=CC=1NC(C1=2)=NC=NC=2NN=C1OCCN1CCN(C)CC1 GHACSHWDWWMCKR-UHFFFAOYSA-N 0.000 claims 1
- MLFHVUFDNZCQAX-UHFFFAOYSA-N n-[3-fluoro-4-(6-methylpyridin-3-yl)oxyphenyl]-3-(2-morpholin-4-ylethoxy)-1h-pyrazolo[3,4-d]pyrimidin-4-amine Chemical compound C1=NC(C)=CC=C1OC(C(=C1)F)=CC=C1NC1=NC=NC2=C1C(OCCN1CCOCC1)=NN2 MLFHVUFDNZCQAX-UHFFFAOYSA-N 0.000 claims 1
- XJIKCEACQPGKHS-UHFFFAOYSA-N n-[3-fluoro-4-(6-methylpyridin-3-yl)oxyphenyl]-3-(2-pyrrolidin-1-ylethoxy)-1h-pyrazolo[3,4-d]pyrimidin-4-amine Chemical compound C1=NC(C)=CC=C1OC(C(=C1)F)=CC=C1NC1=NC=NC2=C1C(OCCN1CCCC1)=NN2 XJIKCEACQPGKHS-UHFFFAOYSA-N 0.000 claims 1
- FZQPWQLURSOWBV-UHFFFAOYSA-N n-[3-fluoro-4-(6-methylpyridin-3-yl)oxyphenyl]-3-[2-(4-methylpiperazin-1-yl)ethoxy]-1h-pyrazolo[3,4-d]pyrimidin-4-amine Chemical compound C1CN(C)CCN1CCOC1=NNC2=NC=NC(NC=3C=C(F)C(OC=4C=NC(C)=CC=4)=CC=3)=C12 FZQPWQLURSOWBV-UHFFFAOYSA-N 0.000 claims 1
- FNYXVRRNSPMXBR-UHFFFAOYSA-N n-[3-methoxy-4-(pyridin-2-ylmethoxy)phenyl]-3-(2-pyrrolidin-1-ylethoxy)-1h-pyrazolo[3,4-d]pyrimidin-4-amine Chemical compound C=1C=C(OCC=2N=CC=CC=2)C(OC)=CC=1NC(C1=2)=NC=NC=2NN=C1OCCN1CCCC1 FNYXVRRNSPMXBR-UHFFFAOYSA-N 0.000 claims 1
- RZOKDOWVJGLDDT-UHFFFAOYSA-N n-[3-methoxy-4-(pyridin-2-ylmethoxy)phenyl]-3-[2-(4-methylpiperazin-1-yl)ethoxy]-1h-pyrazolo[3,4-d]pyrimidin-4-amine Chemical compound C=1C=C(OCC=2N=CC=CC=2)C(OC)=CC=1NC(C1=2)=NC=NC=2NN=C1OCCN1CCN(C)CC1 RZOKDOWVJGLDDT-UHFFFAOYSA-N 0.000 claims 1
- HOARRNDFFQFMGW-UHFFFAOYSA-N n-[3-methyl-4-(6-methylpyridin-3-yl)oxyphenyl]-3-(2-morpholin-4-ylethoxy)-1h-pyrazolo[3,4-d]pyrimidin-4-amine Chemical compound C1=NC(C)=CC=C1OC(C(=C1)C)=CC=C1NC1=NC=NC2=C1C(OCCN1CCOCC1)=NN2 HOARRNDFFQFMGW-UHFFFAOYSA-N 0.000 claims 1
- AMLYVVGYTYLWDS-UHFFFAOYSA-N n-[3-methyl-4-(6-methylpyridin-3-yl)oxyphenyl]-3-(2-pyrrolidin-1-ylethoxy)-1h-pyrazolo[3,4-d]pyrimidin-4-amine Chemical compound C1=NC(C)=CC=C1OC(C(=C1)C)=CC=C1NC1=NC=NC2=C1C(OCCN1CCCC1)=NN2 AMLYVVGYTYLWDS-UHFFFAOYSA-N 0.000 claims 1
- RFZKZFQIQQJPLI-UHFFFAOYSA-N n-[3-methyl-4-(6-methylpyridin-3-yl)oxyphenyl]-3-[2-(4-methylpiperazin-1-yl)ethoxy]-1h-pyrazolo[3,4-d]pyrimidin-4-amine Chemical compound C1CN(C)CCN1CCOC1=NNC2=NC=NC(NC=3C=C(C)C(OC=4C=NC(C)=CC=4)=CC=3)=C12 RFZKZFQIQQJPLI-UHFFFAOYSA-N 0.000 claims 1
- DFFAQXMSNPIZHX-UHFFFAOYSA-N n-[3-methyl-4-(pyridin-2-ylmethoxy)phenyl]-3-(2-morpholin-4-ylethoxy)-1h-pyrazolo[3,4-d]pyrimidin-4-amine Chemical compound C=1C=C(OCC=2N=CC=CC=2)C(C)=CC=1NC(C1=2)=NC=NC=2NN=C1OCCN1CCOCC1 DFFAQXMSNPIZHX-UHFFFAOYSA-N 0.000 claims 1
- HBMUCTKSTFUXDH-UHFFFAOYSA-N n-[3-methyl-4-(pyridin-2-ylmethoxy)phenyl]-3-(2-pyrrolidin-1-ylethoxy)-1h-pyrazolo[3,4-d]pyrimidin-4-amine Chemical compound C=1C=C(OCC=2N=CC=CC=2)C(C)=CC=1NC(C1=2)=NC=NC=2NN=C1OCCN1CCCC1 HBMUCTKSTFUXDH-UHFFFAOYSA-N 0.000 claims 1
- LPAPTKFHFVZVPK-UHFFFAOYSA-N n-[4-[(3-fluorophenyl)methoxy]-3-methoxyphenyl]-3-(2-pyrrolidin-1-ylethoxy)-1h-pyrazolo[3,4-d]pyrimidin-4-amine Chemical compound C=1C=C(OCC=2C=C(F)C=CC=2)C(OC)=CC=1NC(C1=2)=NC=NC=2NN=C1OCCN1CCCC1 LPAPTKFHFVZVPK-UHFFFAOYSA-N 0.000 claims 1
- ONFMFJIKYCBJOF-UHFFFAOYSA-N n-[4-[(3-fluorophenyl)methoxy]-3-methoxyphenyl]-3-[2-(4-methylpiperazin-1-yl)ethoxy]-1h-pyrazolo[3,4-d]pyrimidin-4-amine Chemical compound C=1C=C(OCC=2C=C(F)C=CC=2)C(OC)=CC=1NC(C1=2)=NC=NC=2NN=C1OCCN1CCN(C)CC1 ONFMFJIKYCBJOF-UHFFFAOYSA-N 0.000 claims 1
- ASRZQFXSNXTQMQ-UHFFFAOYSA-N n-[4-[(3-fluorophenyl)methoxy]-3-methylphenyl]-3-[2-(1,4-oxazepan-4-yl)ethoxy]-1h-pyrazolo[3,4-d]pyrimidin-4-amine Chemical compound C=1C=C(OCC=2C=C(F)C=CC=2)C(C)=CC=1NC(C1=2)=NC=NC=2NN=C1OCCN1CCCOCC1 ASRZQFXSNXTQMQ-UHFFFAOYSA-N 0.000 claims 1
- ZUGVWGZKENQLAU-UHFFFAOYSA-N n-[4-[(3-fluorophenyl)methoxy]-3-methylphenyl]-3-[2-(4-methoxypiperidin-1-yl)ethoxy]-1h-pyrazolo[3,4-d]pyrimidin-4-amine Chemical compound C1CC(OC)CCN1CCOC1=NNC2=NC=NC(NC=3C=C(C)C(OCC=4C=C(F)C=CC=4)=CC=3)=C12 ZUGVWGZKENQLAU-UHFFFAOYSA-N 0.000 claims 1
- ASIZGLWKKPLNHP-UHFFFAOYSA-N n-[4-[(3-fluorophenyl)methoxy]-3-methylphenyl]-3-[2-(4-methylpiperazin-1-yl)ethoxy]-1h-pyrazolo[3,4-d]pyrimidin-4-amine Chemical compound C1CN(C)CCN1CCOC1=NNC2=NC=NC(NC=3C=C(C)C(OCC=4C=C(F)C=CC=4)=CC=3)=C12 ASIZGLWKKPLNHP-UHFFFAOYSA-N 0.000 claims 1
- 239000012434 nucleophilic reagent Substances 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 239000000825 pharmaceutical preparation Substances 0.000 claims 1
- 229940127557 pharmaceutical product Drugs 0.000 claims 1
- 125000004307 pyrazin-2-yl group Chemical group [H]C1=C([H])N=C(*)C([H])=N1 0.000 claims 1
- 125000002206 pyridazin-3-yl group Chemical group [H]C1=C([H])C([H])=C(*)N=N1 0.000 claims 1
- 125000006296 sulfonyl amino group Chemical group [H]N(*)S(*)(=O)=O 0.000 claims 1
- 125000003349 3-pyridyl group Chemical group N1=C([H])C([*])=C([H])C([H])=C1[H] 0.000 description 5
- 125000001309 chloro group Chemical group Cl* 0.000 description 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 3
- 0 Cc(c(*)c(*)c(*)c1*)c1N(*)c1c2c(O*)n[n]c2nc(*)n1 Chemical compound Cc(c(*)c(*)c(*)c1*)c1N(*)c1c2c(O*)n[n]c2nc(*)n1 0.000 description 2
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP04292982 | 2004-12-14 | ||
| EP04292982.8 | 2004-12-14 | ||
| EP05291158.3 | 2005-05-30 | ||
| EP05291158 | 2005-05-30 | ||
| PCT/GB2005/004770 WO2006064196A1 (en) | 2004-12-14 | 2005-12-12 | Pyrazolopyrimidine compounds as antitumor agents |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2008523134A JP2008523134A (ja) | 2008-07-03 |
| JP2008523134A5 true JP2008523134A5 (enExample) | 2011-12-22 |
| JP4881875B2 JP4881875B2 (ja) | 2012-02-22 |
Family
ID=35826513
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007546165A Expired - Fee Related JP4881875B2 (ja) | 2004-12-14 | 2005-12-12 | 抗腫瘍剤としてのピラゾロピリミジン化合物 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US7947676B2 (enExample) |
| EP (1) | EP1838712B8 (enExample) |
| JP (1) | JP4881875B2 (enExample) |
| CN (1) | CN101124228B (enExample) |
| AT (1) | ATE501148T1 (enExample) |
| DE (1) | DE602005026865D1 (enExample) |
| WO (1) | WO2006064196A1 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MXPA06002964A (es) | 2003-09-16 | 2006-06-14 | Astrazeneca Ab | Derivados de quinazolina como inhibidores de cinasa de tirosina. |
| GB0322409D0 (en) * | 2003-09-25 | 2003-10-29 | Astrazeneca Ab | Quinazoline derivatives |
| GB0326459D0 (en) | 2003-11-13 | 2003-12-17 | Astrazeneca Ab | Quinazoline derivatives |
| DE602005010824D1 (de) | 2004-02-03 | 2008-12-18 | Astrazeneca Ab | Chinazolinderivate |
| JP2008231004A (ja) * | 2007-03-19 | 2008-10-02 | Sumitomo Seika Chem Co Ltd | アルコキシ−２−メルカプトベンゾチアゾールの製造方法 |
| JP5823657B1 (ja) | 2012-11-08 | 2015-11-25 | ファイザー・インク | ドーパミンｄ１リガンドとしての複素芳香族化合物 |
| CN105829296A (zh) | 2013-12-18 | 2016-08-03 | 巴斯夫欧洲公司 | 带有亚胺衍生的取代基的唑类化合物 |
| US9616063B2 (en) | 2014-12-01 | 2017-04-11 | Astrazeneca Ab | 1-[2-(aminomethyl)benzyl]-2-thioxo-1,2,3,5-tetrahydro-4H-pyrrolo[3,2-d]pyrimidin-4-ones as inhibitors of myeloperoxidase |
| WO2017184775A1 (en) * | 2016-04-19 | 2017-10-26 | The Regents Of The University Of California | Erbb inhibitors and uses thereof |
Family Cites Families (103)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5538325A (en) | 1978-09-11 | 1980-03-17 | Sankyo Co Ltd | 4-anilinoquinazoline derivative and its preparation |
| US4335127A (en) | 1979-01-08 | 1982-06-15 | Janssen Pharmaceutica, N.V. | Piperidinylalkyl quinazoline compounds, composition and method of use |
| GB2160201B (en) | 1984-06-14 | 1988-05-11 | Wyeth John & Brother Ltd | Quinazoline and cinnoline derivatives |
| KR910006138B1 (ko) | 1986-09-30 | 1991-08-16 | 에자이 가부시끼가이샤 | 환상아민 유도체 |
| IL89029A (en) | 1988-01-29 | 1993-01-31 | Lilly Co Eli | Fungicidal quinoline and cinnoline derivatives, compositions containing them, and fungicidal methods of using them |
| US4921863A (en) | 1988-02-17 | 1990-05-01 | Eisai Co., Ltd. | Cyclic amine derivatives |
| CA1340821C (en) | 1988-10-06 | 1999-11-16 | Nobuyuki Fukazawa | Heterocyclic compounds and anticancer-drug reinforcing agents containing them as effective components |
| US5710158A (en) | 1991-05-10 | 1998-01-20 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Aryl and heteroaryl quinazoline compounds which inhibit EGF and/or PDGF receptor tyrosine kinase |
| US5721237A (en) | 1991-05-10 | 1998-02-24 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Protein tyrosine kinase aryl and heteroaryl quinazoline compounds having selective inhibition of HER-2 autophosphorylation properties |
| AU658646B2 (en) | 1991-05-10 | 1995-04-27 | Rhone-Poulenc Rorer International (Holdings) Inc. | Bis mono-and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinase |
| NZ243082A (en) | 1991-06-28 | 1995-02-24 | Ici Plc | 4-anilino-quinazoline derivatives; pharmaceutical compositions, preparatory processes, and use thereof |
| US5187168A (en) | 1991-10-24 | 1993-02-16 | American Home Products Corporation | Substituted quinazolines as angiotensin II antagonists |
| AU661533B2 (en) | 1992-01-20 | 1995-07-27 | Astrazeneca Ab | Quinazoline derivatives |
| WO1993017682A1 (en) | 1992-03-04 | 1993-09-16 | Abbott Laboratories | Angiotensin ii receptor antagonists |
| GB9323290D0 (en) | 1992-12-10 | 1994-01-05 | Zeneca Ltd | Quinazoline derivatives |
| IL112249A (en) | 1994-01-25 | 2001-11-25 | Warner Lambert Co | Pharmaceutical compositions containing di and tricyclic pyrimidine derivatives for inhibiting tyrosine kinases of the epidermal growth factor receptor family and some new such compounds |
| JPH083144A (ja) | 1994-06-21 | 1996-01-09 | Chugai Pharmaceut Co Ltd | キナゾリン及びキノリン誘導体 |
| GB9510757D0 (en) | 1994-09-19 | 1995-07-19 | Wellcome Found | Therapeuticaly active compounds |
| TW321649B (enExample) | 1994-11-12 | 1997-12-01 | Zeneca Ltd | |
| GB2295387A (en) | 1994-11-23 | 1996-05-29 | Glaxo Inc | Quinazoline antagonists of alpha 1c adrenergic receptors |
| GB9424233D0 (en) | 1994-11-30 | 1995-01-18 | Zeneca Ltd | Quinazoline derivatives |
| DE69522717T2 (de) | 1995-03-30 | 2002-02-14 | Pfizer Inc., New York | Chinazolinderivate |
| AU711592B2 (en) | 1995-04-03 | 1999-10-14 | Novartis Ag | Pyrazole derivatives and processes for the preparation thereof |
| GB9508535D0 (en) | 1995-04-27 | 1995-06-14 | Zeneca Ltd | Quinazoline derivative |
| EP0824525B1 (en) | 1995-04-27 | 2001-06-13 | AstraZeneca AB | Quinazoline derivatives |
| GB9508537D0 (en) | 1995-04-27 | 1995-06-14 | Zeneca Ltd | Quinazoline derivatives |
| GB9508538D0 (en) | 1995-04-27 | 1995-06-14 | Zeneca Ltd | Quinazoline derivatives |
| GB9508565D0 (en) | 1995-04-27 | 1995-06-14 | Zeneca Ltd | Quiazoline derivative |
| US5747498A (en) | 1996-05-28 | 1998-05-05 | Pfizer Inc. | Alkynyl and azido-substituted 4-anilinoquinazolines |
| US6046206A (en) | 1995-06-07 | 2000-04-04 | Cell Pathways, Inc. | Method of treating a patient having a precancerous lesions with amide quinazoline derivatives |
| CA2223081C (en) * | 1995-06-07 | 2001-03-06 | Pfizer Inc. | Heterocyclic ring-fused pyrimidine derivatives |
| GB9514265D0 (en) | 1995-07-13 | 1995-09-13 | Wellcome Found | Hetrocyclic compounds |
| DE69634900T2 (de) | 1995-09-11 | 2006-05-18 | Osteoarthritis Sciences, Inc., Cambridge | Proteintyrosine-kinaseinhibitoren zur behandlung der osteoarthritis |
| AR004010A1 (es) | 1995-10-11 | 1998-09-30 | Glaxo Group Ltd | Compuestos heterociclicos |
| GB9624482D0 (en) | 1995-12-18 | 1997-01-15 | Zeneca Phaema S A | Chemical compounds |
| BR9702049B1 (pt) | 1996-01-31 | 2010-08-10 | sistema distribuidor contendo dois compartimentos para a dosagem simultánea de duas composições aquosas. | |
| US5760041A (en) | 1996-02-05 | 1998-06-02 | American Cyanamid Company | 4-aminoquinazoline EGFR Inhibitors |
| JP4471404B2 (ja) | 1996-02-13 | 2010-06-02 | アストラゼネカ ユーケイ リミテッド | Ｖｅｇｆインヒビターとしてのキナゾリン誘導体 |
| GB9603095D0 (en) | 1996-02-14 | 1996-04-10 | Zeneca Ltd | Quinazoline derivatives |
| GB9603097D0 (en) | 1996-02-14 | 1996-04-10 | Zeneca Ltd | Quinazoline compounds |
| HU228446B1 (en) | 1996-04-12 | 2013-03-28 | Warner Lambert Co | Kinazoline derivatives as irreversible inhibitors of protein-kinase, pharmaceutical compositions containing these compounds and use thereof |
| GB9607729D0 (en) | 1996-04-13 | 1996-06-19 | Zeneca Ltd | Quinazoline derivatives |
| ES2191187T3 (es) | 1996-07-13 | 2003-09-01 | Glaxo Group Ltd | Compuestos heteroaromaticos biciclicos como inhibidores de la proteina tirosin-quinasa. |
| JP4386967B2 (ja) | 1996-07-13 | 2009-12-16 | グラクソ、グループ、リミテッド | プロテインチロシンキナーゼ阻害剤としての縮合複素環式化合物 |
| HRP970371A2 (en) | 1996-07-13 | 1998-08-31 | Kathryn Jane Smith | Heterocyclic compounds |
| US6004967A (en) | 1996-09-13 | 1999-12-21 | Sugen, Inc. | Psoriasis treatment with quinazoline compounds |
| GB9718972D0 (en) | 1996-09-25 | 1997-11-12 | Zeneca Ltd | Chemical compounds |
| ID18494A (id) | 1996-10-02 | 1998-04-16 | Novartis Ag | Turunan pirazola leburan dan proses pembuatannya |
| WO1998014450A1 (en) | 1996-10-02 | 1998-04-09 | Novartis Ag | Pyrimidine derivatives and processes for the preparation thereof |
| WO1998014449A1 (en) | 1996-10-02 | 1998-04-09 | Novartis Ag | Fused pyrazole derivatives and processes for their preparation |
| EP0837063A1 (en) | 1996-10-17 | 1998-04-22 | Pfizer Inc. | 4-Aminoquinazoline derivatives |
| JP4713698B2 (ja) | 1997-03-05 | 2011-06-29 | スージェン， インク． | 疎水性薬剤の処方 |
| AR012634A1 (es) | 1997-05-02 | 2000-11-08 | Sugen Inc | Compuesto basado en quinazolina, composicion famaceutica que lo comprende, metodo para sintetizarlo, su uso, metodos de modulacion de la funcion deserina/treonina proteinaquinasa con dicho compuesto y metodo in vitro para identificar compuestos que modulan dicha funcion |
| EP0980244B1 (en) | 1997-05-06 | 2003-06-04 | Wyeth Holdings Corporation | Use of quinazoline compounds for the treatment of polycystic kidney disease |
| US5929080A (en) | 1997-05-06 | 1999-07-27 | American Cyanamid Company | Method of treating polycystic kidney disease |
| ZA986732B (en) | 1997-07-29 | 1999-02-02 | Warner Lambert Co | Irreversible inhibitiors of tyrosine kinases |
| TW436485B (en) | 1997-08-01 | 2001-05-28 | American Cyanamid Co | Substituted quinazoline derivatives |
| KR20010031813A (ko) | 1997-11-06 | 2001-04-16 | 윌리암 에이취 캘넌, 에곤 이 버그 | 결장 폴립 치료용 티로신 키나제 억제제로서의 퀴나졸린유도체의 용도 |
| JP4245682B2 (ja) | 1997-12-25 | 2009-03-25 | 協和発酵キリン株式会社 | キノリン誘導体、イソキノリン誘導体、およびシンノリン誘導体、並びに抗炎症剤および抗アレルギー剤 |
| GB9800569D0 (en) | 1998-01-12 | 1998-03-11 | Glaxo Group Ltd | Heterocyclic compounds |
| GB9800575D0 (en) | 1998-01-12 | 1998-03-11 | Glaxo Group Ltd | Heterocyclic compounds |
| MXPA00011773A (es) | 1998-05-28 | 2002-06-04 | Parker Hughes Inst | Quinazolinas para tratar tumores en el cerebro. |
| JP2004504259A (ja) | 1998-06-30 | 2004-02-12 | パーカー ヒューズ インスティテュート | Ｊａｋ−３インヒビターを用いたｃ−ｊｕｎ発現の阻害方法 |
| US6384223B1 (en) | 1998-07-30 | 2002-05-07 | American Home Products Corporation | Substituted quinazoline derivatives |
| US6297258B1 (en) | 1998-09-29 | 2001-10-02 | American Cyanamid Company | Substituted 3-cyanoquinolines |
| UA71945C2 (en) | 1999-01-27 | 2005-01-17 | Pfizer Prod Inc | Substituted bicyclic derivatives being used as anticancer agents |
| KR20020068261A (ko) | 1999-02-27 | 2002-08-27 | 베링거 잉겔하임 파르마 카게 | 티로신 키나제에 의해 매개되는 신호 변환에 대한 억제효과를 갖는 4-아미노-퀴나졸린 및 퀴놀린 유도체 |
| US6080747A (en) | 1999-03-05 | 2000-06-27 | Hughes Institute | JAK-3 inhibitors for treating allergic disorders |
| UA73993C2 (uk) * | 2000-06-06 | 2005-10-17 | Астразенека Аб | Хіназолінові похідні для лікування пухлин та фармацевтична композиція |
| US20020082270A1 (en) | 2000-08-26 | 2002-06-27 | Frank Himmelsbach | Aminoquinazolines which inhibit signal transduction mediated by tyrosine kinases |
| NZ516873A (en) | 2001-02-12 | 2003-11-28 | Warner Lambert Co | Compositions containing retinoids and erb inhibitors and their use in inhibiting retinoid skin damage |
| CA2442742A1 (en) | 2001-02-21 | 2002-08-29 | Mitsubishi Pharma Corporation | Quinazoline derivatives |
| US6562319B2 (en) | 2001-03-12 | 2003-05-13 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Radiolabeled irreversible inhibitors of epidermal growth factor receptor tyrosine kinase and their use in radioimaging and radiotherapy |
| US20040176361A1 (en) | 2001-05-23 | 2004-09-09 | Masakazu Fujio | Fused heterocyclic compound and medicinal use thereof |
| GB0126433D0 (en) * | 2001-11-03 | 2002-01-02 | Astrazeneca Ab | Compounds |
| HUP0401646A2 (hu) * | 2001-11-03 | 2004-12-28 | Astrazeneca Ab, | Tumorellenes hatású kinazolinszármazékok, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények |
| TW200813014A (en) * | 2002-03-28 | 2008-03-16 | Astrazeneca Ab | Quinazoline derivatives |
| US6924285B2 (en) | 2002-03-30 | 2005-08-02 | Boehringer Ingelheim Pharma Gmbh & Co. | Bicyclic heterocyclic compounds, pharmaceutical compositions containing these compounds, their use and process for preparing them |
| KR101064530B1 (ko) | 2002-03-30 | 2011-09-14 | 베링거 잉겔하임 파르마 게엠베하 운트 코 카게 | 티로신 키나아제 억제제로서의 4-(ｎ-페닐아미노)-퀴나졸린/퀴놀린, 이를 함유하는 약제학적 조성물 및 이의 제조방법 |
| GB0309009D0 (en) * | 2003-04-22 | 2003-05-28 | Astrazeneca Ab | Quinazoline derivatives |
| GB0309850D0 (en) * | 2003-04-30 | 2003-06-04 | Astrazeneca Ab | Quinazoline derivatives |
| JP2007500177A (ja) * | 2003-07-29 | 2007-01-11 | アストラゼネカ アクチボラグ | チロシンキナーゼ阻害剤としてのピペリジルキナゾリン誘導体 |
| GB0317665D0 (en) * | 2003-07-29 | 2003-09-03 | Astrazeneca Ab | Qinazoline derivatives |
| DE602004022180D1 (de) * | 2003-09-16 | 2009-09-03 | Astrazeneca Ab | Chinazolinderivate |
| EP1664028A1 (en) * | 2003-09-16 | 2006-06-07 | AstraZeneca AB | Quinazoline derivatives as tyrosine kinase inhibitors |
| GB0321648D0 (en) * | 2003-09-16 | 2003-10-15 | Astrazeneca Ab | Quinazoline derivatives |
| MXPA06002964A (es) * | 2003-09-16 | 2006-06-14 | Astrazeneca Ab | Derivados de quinazolina como inhibidores de cinasa de tirosina. |
| AU2004272345A1 (en) * | 2003-09-16 | 2005-03-24 | Astrazeneca Ab | Quinazoline derivatives |
| US8318752B2 (en) * | 2003-09-19 | 2012-11-27 | Astrazeneca Ab | 4-(3-chloro-2-fluoroanilino)-7-methoxy-6-{[1-(N-methylcarbamoyl-methyl)piperidin-4-yl]oxy}quinazoline, its pharmaceutically acceptable salts, and pharmaceutical compositions comprising the same |
| ATE353888T1 (de) * | 2003-09-19 | 2007-03-15 | Astrazeneca Ab | Chinazolinderivate |
| GB0322409D0 (en) * | 2003-09-25 | 2003-10-29 | Astrazeneca Ab | Quinazoline derivatives |
| EP1670786A1 (en) * | 2003-09-25 | 2006-06-21 | Astrazeneca AB | Quinazoline derivatives |
| DE10350717A1 (de) | 2003-10-30 | 2005-06-02 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Verwendung von Tyrosinkinase-Inhibitoren zur Behandlung inflammatorischer Prozesse |
| GB0326459D0 (en) * | 2003-11-13 | 2003-12-17 | Astrazeneca Ab | Quinazoline derivatives |
| DE602005010824D1 (de) * | 2004-02-03 | 2008-12-18 | Astrazeneca Ab | Chinazolinderivate |
| WO2005118572A1 (en) * | 2004-06-04 | 2005-12-15 | Astrazeneca Ab | Quinazoline derivatives as erbb receptor tyrosine kinases |
| GB0504474D0 (en) * | 2005-03-04 | 2005-04-13 | Astrazeneca Ab | Chemical compounds |
| GB0504475D0 (en) * | 2005-03-04 | 2005-04-13 | Astrazeneca Ab | Chemical compounds |
| GB0508717D0 (en) * | 2005-04-29 | 2005-06-08 | Astrazeneca Ab | Chemical compounds |
| GB0508715D0 (en) * | 2005-04-29 | 2005-06-08 | Astrazeneca Ab | Chemical compounds |
| US7820683B2 (en) * | 2005-09-20 | 2010-10-26 | Astrazeneca Ab | 4-(1H-indazol-5-yl-amino)-quinazoline compounds as erbB receptor tyrosine kinase inhibitors for the treatment of cancer |
| JP2009508917A (ja) * | 2005-09-20 | 2009-03-05 | アストラゼネカ アクチボラグ | 抗癌剤としてのキナゾリン誘導体 |
| ATE443053T1 (de) * | 2005-12-02 | 2009-10-15 | Astrazeneca Ab | Als inhibitoren von erbb-tyrosinkinase verwendete chinazoleinderivate |
-
2005
- 2005-12-12 WO PCT/GB2005/004770 patent/WO2006064196A1/en not_active Ceased
- 2005-12-12 EP EP05818622A patent/EP1838712B8/en not_active Expired - Lifetime
- 2005-12-12 AT AT05818622T patent/ATE501148T1/de not_active IP Right Cessation
- 2005-12-12 CN CN2005800483311A patent/CN101124228B/zh not_active Expired - Fee Related
- 2005-12-12 JP JP2007546165A patent/JP4881875B2/ja not_active Expired - Fee Related
- 2005-12-12 DE DE602005026865T patent/DE602005026865D1/de not_active Expired - Lifetime
- 2005-12-12 US US11/792,921 patent/US7947676B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2020250211B2 (en) | Bicyclic heterocycles as fgfr inhibitors | |
| KR101985050B1 (ko) | 피라진카르복사미드 화합물 | |
| AU2009264934B2 (en) | Pyrimidine derivatives as kinase inhibitors | |
| US10010547B2 (en) | Pharmaceutical compounds | |
| AU2022349569A1 (en) | Pyridine derivative and use thereof | |
| CA2671744A1 (en) | Compounds and compositions as protein kinase inhibitors | |
| JPWO2020231806A5 (enExample) | ||
| JP2007505874A5 (enExample) | ||
| JP2010510319A5 (enExample) | ||
| JP2012525395A5 (enExample) | ||
| JP2008501675A (ja) | Ｅｒｂｂ受容体型チロシンキナーゼとしてのキナゾリン誘導体 | |
| JP2008523134A5 (enExample) | ||
| RU2009105829A (ru) | СОЕДИНЕНИЯ И КОМПОЗИЦИИ В КАЧЕСТВЕ ИНГИБИТОРОВ ITPKb | |
| CN105377261B (zh) | 取代的吲哚‑5‑酚衍生物和它们的治疗应用 | |
| CN107635553B (zh) | 作为激酶抑制剂的嘧啶衍生物和它们的治疗应用 | |
| JP4881875B2 (ja) | 抗腫瘍剤としてのピラゾロピリミジン化合物 | |
| TH2101006978A (th) | สารยับยั้งการกินตัวเองของเซลล์ชนิดเฮเทอโรแอริลอะมิโนไพริดีนเอไมด์และวิธีการใช้สารนั้น | |
| RU2020138615A (ru) | Триазолпиримидиновые соединения и их применение в лечении рака | |
| HK40022691B (en) | Bicyclic heterocycles as fgfr inhibitors | |
| HK40022691A (en) | Bicyclic heterocycles as fgfr inhibitors | |
| HK1246794B (en) | Bicyclic heterocycles as fgfr inhibitors |